Sulfonylureas (SUs) and dipeptidyl peptidase-4 (DPP-4) inhibitors are available for second-line treatment after metformin in type 2 diabetes mellitus (T2D). Gliclazide modified release (MR)...
Research has shown that type 2 diabetics prefer fewer injections. Insulin icodec is developed to treat patients with diabetes. Icodec insulin has a half-life...
Left ventricular (LV) function and myocardial viability are among the most important determinants of prognosis in patients with coronary artery disease. Although survival of...
Many studies have discussed the metabolic benefits of exercise in different health conditions, such as pregnancy. However, the mechanism of how these benefits get...
Short-term and Long-term Feasibility, Safety, and Efficacy of High-Intensity Interval Training in Cardiac Rehabilitation: The FITR Heart Study Randomized Clinical Trial As compared to...
Due to past evidence and guidelines, the use of ticagrelor after myocardial infarction is increased. However, there is a limited study conducted for investigating...
